Physician profile
Matthew Clayson
NPI 1245898279
$10,430.38
in general payments reported to CMS, 2019-2025
12 companies · $2,261 in 2025
The $2,261 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,149 · 2023: $3,630 · 2024: $1,391 · 2025: $2,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,615 · Travel and Lodging: $2,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,615.24 |
| Travel and Lodging | $2,666.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,335.81 | 2022-2025 | Prostep, Salvation, N/A |
| Gemini Mountain Medical, LLC | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $956.03 | 2022-2025 | Grafix Pl, Stravix, Evos |
| Amgen INC. | $171.66 | 2024-2025 | Krystexxa |
| Tactile Systems Technology INC | $158.23 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bioventus LLC | $149.21 | 2023-2025 | Stimrouter Implantable Kit, Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $136.30 | 2022-2025 | |
| Mimedx Group, INC. | $132.94 | 2024 | |
| Medtronic, INC. | $104.97 | 2024 | Hawkone |
| Abbvie INC. | $43.86 | 2022-2023 | Dalvance |
| Paragon 28, INC. | $23.90 | 2025 | Precision Mis Bunion |
| Averitas Pharma INC. | $17.47 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Clayson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.